Response of Alkylresorcinols to Different Cereals

August 2, 2018 updated by: CDUuser, Nestlé

Response of Alkylresorcinols and Other Biomarkers to Different Cereals

Cereal grains contain a wide variety of different phytochemicals which may play different roles in physiology. Their response in plasma and urine after a meal is poorly defined for most cereals. This study will investigate the plasma response and urinary excretion of cereal compounds after eating 6 different types of cereal preparation, with a focus on alkylresorcinols.

Study Overview

Detailed Description

This was a cross-over, randomized, double blind study with 6 arms (flours of different composition). Thirteen subjects completed the trial, where 100 g of each flour, mixed with 300 mL milk, was fed to all subjects.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vaud
      • Lausanne, Vaud, Switzerland, 1000
        • NESTEC / Clinical Development Unit / Metabolic Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy
  • Normal-overweight (BMI 19-28 kg/m2)
  • Non-smokers

Exclusion Criteria:

  • Regular consumers of wholegrain cereals
  • Allergy to cereal or milk products

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Refined wheat flour
A negative control flour to serve as a reference.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
ACTIVE_COMPARATOR: Esterase wholegrain wheat flour
Wholegrain wheat flour treated with esterases to release phenolics (positive control for phenolic acids)
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
EXPERIMENTAL: Wholegrain wheat flour
Flour with unknown response
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
EXPERIMENTAL: Liquid whole grain wheat flour
Test flour with unknown response.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
EXPERIMENTAL: Wholegrain barley flour
Test flour with unknown response.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
EXPERIMENTAL: Liquid wholegrain barley flour
Test flour with unknown response.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma Alkylresorcinol Compounds
Time Frame: From 0 to 48 h post dose.
Area under the curve (AUC) over baseline of alkylresorcinol compounds are measured for the 6 interventional arms. Time points are: t = 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 24 and 48 h after product intake.
From 0 to 48 h post dose.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma and Urinary Betaine
Time Frame: From 0 to 48 hours post dose
From 0 to 48 hours post dose
Phenolic Acids
Time Frame: 0-48 h post dose
Phenolic acids in plasma and urine
0-48 h post dose

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Alastair B Ross, PhD, Nestlé

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (ACTUAL)

August 1, 2012

Study Completion (ACTUAL)

December 1, 2012

Study Registration Dates

First Submitted

January 30, 2011

First Submitted That Met QC Criteria

January 31, 2011

First Posted (ESTIMATE)

February 1, 2011

Study Record Updates

Last Update Posted (ACTUAL)

August 31, 2018

Last Update Submitted That Met QC Criteria

August 2, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Esterase wholegrain wheat flour

3
Subscribe